All Oncology Clinical Trials:
Oncology Clinical Trial: Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Clinical Trial Protocol # ACNS1123 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer.
Clinical Trial | Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: A Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Trial | Bone Marrow Transplant/Hematopoietic Stem Cell Transplant | Contact (714) 509-8646
Oncology Clinical Trial: Gastrointestinal Microbe Population Changes in Newly Diagnosed Pediatric Pre-B Acute Lymphoblastic Leukemia Patients
Clinical Trial | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Molecular Profiles of Refractory and Recurrent Childhood, Adolescent, and Young Adult Cancers
Clinical Trial | Adolescents and Young Adults, Biology/Genomics, Brain Tumor/Central Nervous System/Neuro-Oncology, Leukemia/Lymphoma, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Clinical Trial Protocol # 10-CBA | Bone Marrow Transplant/Hematopoietic Stem Cell Transplant | Contact (714) 509-8646
Oncology Clinical Trial: Collection of Samples and Data for the National Marrow Donor Program Repository
Clinical Trial | Bone Marrow Transplant/Hematopoietic Stem Cell Transplant | Contact (714) 509-8646
Oncology Clinical Trial: Childhood Cancer Survivor Study
Clinical Trial | Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
Clinical Trial Protocol # ANHL12P1 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
Clinical Trial | Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: WEE1 Inhibitor MK-1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Clinical Trial Protocol # ADVL1217 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Clinical Trial Protocol # ACCL1131 | Bone Marrow Transplant/Hematopoietic Stem Cell Transplant, Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Ketogenic Diet as a Complementary Metabolic Therapy in Pediatric Recurrent/Refractory Solid Tumors including Central Nervous System (CNS) Tumors
Clinical Trial | Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors, Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Treatment for Advanced B-Cell Lymphoma
Clinical Trial | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Clinical Trial Protocol # ARST1321 | Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Pazopanib Paediatric Phase II Trial Children’s Oncology Group (COG) in Solid Tumors
Clinical Trial Protocol # ADVL1322 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Clinical Trial Protocol # ALTE11C1 | Adolescents and Young Adults, Fertility, Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Clinical Trial Protocol # ANBL1232 | Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Study of a Tool for Advanced Care Planning in Young Adults Cancer and Other Life Threatening Illnesses
Clinical Trial | Adolescents and Young Adults, Recurrent/Refractory Cancer, Supportive Care, Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Clinical Trial Protocol # ADVL1312 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Cognitive Training To Promote Neuroplasticity and Neural Re-Circuitry in Chemotherapy-Associated Cognitive Impairment: A Pilot Study
Clinical Trial | Supportive Care, Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma
Clinical Trial Protocol # AHOD1331 | Adolescents and Young Adults, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Clinical Trial Protocol # AEWS1221 | Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
Clinical Trial Protocol # AALL1231 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
Clinical Trial Protocol # ADVL1412 | Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
